Free shipping on all orders over $ 500

Eliglustat tartrate

Cat. No. M9733
Eliglustat tartrate Structure
Synonym:

Genz-112638; Eliglustat hemitartrate

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
5mg USD 110  USD110 In stock
10mg USD 150  USD150 In stock
25mg USD 220  USD220 In stock
50mg USD 310  USD310 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Eliglustat tartrate is a potent and selective glucosylceramide synthase inhibitor with IC50 of 24 nM. Incubating K562 or B16/F10 cells for 72 h with increasing amounts of Genz-112638 (0.6-1000 nM) results in a dose-dependent reduction of cell surface levels of both GM1 and GM3.

Chemical Information
Molecular Weight 959.17
Formula C50H78N4O14
CAS Number 928659-70-5
Solubility (25°C) Water ≥ 48 mg/mL
DMSO ≥ 48 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Annalisa Sechi, et al. Ther Clin Risk Manag. Profile of eliglustat tartrate in the management of Gaucher disease

[2] Kerry Anne McEachern, et al. Mol Genet Metab. A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease

Related Products
M3554 (anti-GD2 ADC)

M3554 is a novel anti-GD2 ADC designed based on humanized ch14.18 anti-GD2 antibody. M3554 has anti-tumor activity.

OGT2115

OGT2115 is a potent, cell-permeable and orally active heparanase inhibitor with an IC50 of 0.4 μM. OGT2115 has anti-angiogenic properties (IC50 = 1 μM).

DiosMetin 7-O-β-D-Glucuronide

DiosMetin 7-O-β-D-Glucuronide is an antioxidant constituent in the fruits of Luffa cylindrical.

Bendazac L-Lysine

Bendazac L-Lysine is an aldose reductase (AR) inhibitor, which can be used to inhibit the activity of AR in the eye to prevent cataracts.

Ro5-3335

Ro5-3335 acts as an inhibitor of core binding factor (CBF) leukemia. Ro5-3335 is a RUNX1-CBFβ interaction inhibitor that represses RUNX1/CBFB-dependent transactivation.

  Catalog
Abmole Inhibitor Catalog




Keywords: Eliglustat tartrate, Genz-112638; Eliglustat hemitartrate supplier, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.